Loss of SHP-2 activity in CD4 + T cells promotes melanoma progression and metastasis

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Zhang, Tao ^a   Guo, Wenjie ^a   Yang, Yang ^a   Liu, Wen ^a   Guo, Lele ^a   Gu, Yanhong ^b   Shu, Yongqian ^b   Wang, Lu ^a   Wu, Xuefeng ^a   Hua, Zichun ^a   Ke, Yuehai ^a   Sun, Yang ^c   Shen, Yan ^a   Xu, Qiang ^a  

^a NANJING UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; DISEASE COURSE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER TUMOR; LUNG TUMOR; MALE; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84885155172     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02845     Document Type: Article

References (41)

1. Neel, B. G., Gu, H. & Pao, L. The Shping news: SH2 domain-Containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28, 284-293 (2003).
2. Chong, Z. Z. & Maiese, K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: Diversified control of cell growth, inflammation, and injury. Histol Histopathol 22, 1251-1267 (2007).
3. Mohi, M. G. & Neel, B. G. The role of Shp2 (PTPN11) in cancer. Curr Opin Genet Dev 17, 23-30 (2007).
4. Bard-Chapeau, E. A. et al. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 19, 629-639 (2011).
5. Jiang, C. et al. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma. J Cancer Res Clin Oncol 138, 637-646 (2012).
6. Li, S., Hsu, D. D., Wang, H. & Feng, G. S. Dual faces of SH2-Containing proteintyrosine phosphatase Shp2/PTPN11 in tumorigenesis. Front Med 6, 275-279 (2012).
7. Perales, M. A. & Wolchok, J. D. CD4 help and tumor immunity: Beyond the activation of cytotoxic T lymphocytes. Ann Surg Oncol 11, 881-882 (2004).
8. DeNardo, D. G. et al. CD4(1) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91-102 (2009).
9. Purdy, A. K. & Campbell, K. S. SHP-2 expression negatively regulates NK cell function. J Immunol 183, 7234-7243 (2009).
10. Salmond, R. J. & Alexander, D. R. SHP2 forecast for the immune system: Fog gradually clearing. Trends Immunol 27, 154-160 (2006).
11. Lorenz, U. SHP-1 and SHP-2 in T cells: Two phosphatases functioning at many levels. Immunol Rev 228, 342-359 (2009).
12. Salmond, R. J., Huyer, G., Kotsoni, A., Clements, L. & Alexander, D. R. The src homology 2 domain-Containing tyrosine phosphatase 2 regulates primary Tdependent immune responses and Th cell differentiation. J Immunol 175, 6498-6508 (2005).
13. Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H. & Riley, J. L. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-Based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 173, 945-954 (2004).
14. Parry, R. V. et al. CTLA-4 and PD-1 receptors inhibit T-Cell activation by distinct mechanisms. Mol Cell Biol 25, 9543-9553 (2005).
15. Kwon, J. et al. Receptor-Stimulated oxidation of SHP-2 promotes T-Cell adhesion through SLP-76-ADAP. EMBO J 24, 2331-2341 (2005).
16. Ahmadzadeh, M. et al. Tumor antigen-Specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537-1544 (2009).
17. Wang, S. F. et al. Early T cell signalling is reversibly altered in PD-11 T lymphocytes infiltrating human tumors. PLoS One 6, e17621 (2011).
18. Gabrilovich, D. I. & Nagaraj, S. Myeloid-Derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9, 162-174 (2009).
19. Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P. & Bronte, V. Tumor-Induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 222, 162-179 (2008).
20. Ostrand-Rosenberg, S. & Sinha, P. Myeloid-Derived suppressor cells: Linking inflammation and cancer. J Immunol 182, 4499-4506 (2009).
21. Aceto, N. et al. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-Initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat Med 18, 529-537 (2012).
22. De Visser, K. E., Eichten, A. & Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6, 24-37 (2006).
23. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-Related inflammation. Nature 454, 436-444 (2008).
24. Yu,H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7, 41-51 (2007).
25. Coulombe, G. et al. Epithelial tyrosine phosphatase SHP-2 protects against intestinal inflammation in mice. Mol Cell Biol 33, 2275-2284 (2013).
26. Nguyen, T. V., Ke, Y., Zhang, E. E. & Feng, G. S. Conditional deletion of Shp2 tyrosine phosphatase in thymocytes suppresses both pre-TCR and TCR signals. J Immunol 177, 5990-5996 (2006).
27. Koebel, C. M. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903-907 (2007).
28. Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570 (2011).
29. Vesely, M. D., Kershaw,M. H., Schreiber, R. D. & Smyth,M. J. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 29, 235-271 (2011).
30. Bunt, S. K. et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-Derived suppressor cells and limits tumor progression. Cancer Res 67, 10019-10026 (2007).
31. Tu, S. et al.Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-Derived suppressor cells in mice. Cancer Cell 14, 408-419 (2008).
32. Zhao, F. et al. Activation of p38 mitogen-Activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma. Clin Cancer Res 15, 4382-4390 (2009).
33. Meyer, C. et al. Chronic inflammation promotes myeloid-Derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A 108, 17111-17116 (2011).
34. Dawson, M. I. et al. Adamantyl-Substituted retinoid-Derived molecules that interact with the orphan nuclear receptor small heterodimer partner: Effects of replacing the 1-Adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domaincontaining protein tyrosine phosphatase-2 activity. J Med Chem 51, 5650-5662 (2008).
35. Irandoust, M., Van Den Berg, T. K., Kaspers, G. J. & Cloos, J. Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domaincontaining tyrosine phosphatases (SHPs). Anticancer Agents Med Chem 9, 212-220 (2009).
36. Win-Piazza, H. et al. Enhanced anti-Melanoma efficacy of interferon alfa-2b via inhibition of Shp2. Cancer Lett 320, 81-85 (2012).
37. Zhang, E. E., Chapeau, E., Hagihara, K. & Feng, G. S. Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci U S A 101, 16064-16069 (2004).
38. Dong, X., Li, J., Li, S., Zhang, J. & Hua, Z. C. A novel genotyping strategy based on allele-Specific inverse PCR for rapid and reliable identification of conditional FADD knockout mice. Mol Biotechnol 38, 129-135 (2008).
39. Wu, X. et al. Selective Sequestration of STAT1 in the Cytoplasm via Phosphorylated SHP-2 Ameliorates Murine Experimental Colitis. J Immunol 189, 3497-3507 (2012).
40. Wang, L. et al. An anticancer effect of curcumin mediated by down-Regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells. Mol Pharmacol 76, 1238-1245 (2009).
41. Wu, X. et al. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 164, 2039-2054 (2004).